Incline Village, Nevada, United States | Fund Name | Location |
| A.G. Edwards Capital Partners | Missouri, St Louis, United States |
| Bankia | Community of Madrid, Madrid, Spain |
| Canderel | Canada, Montreal, Quebec |
| Credit Agricole CIB | France, Ile-de-France, Paris |
| Elite Learning | Beijing, China, Haidian |
| Huajin Fund | Beijing, Beijing, China |
| KD Partners | - |
| Laconia Ventures | New York, New York, United States |
| M.D. Sass | New York, New York, United States |
| NextGen Venture Partners | Baltimore, Maryland, United States |
| Playfair Capital | England, London, United Kingdom |
| Revival Healthcare Capital | Austin, Texas, United States |
| Rivet Ventures | California, San Francisco, United States |
| Salus Partners SA | Lausanne, Switzerland, Vaud |
| Seaya Ventures | Madrid, Madrid, Spain |
| South Dakota Equity Partners | Sioux Falls, South Dakota, United States |
| Synergy Ventures | California, Menlo Park, United States |
| Tohan | Japan, Tokyo |
| Zubr Capital | Belarus, Minsk |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Nine Biopharm | $6M | 21 Dec 2021 | Suwon, Ch'ungch'ong-namdo, South Korea | ||
BloomThis | $600K | 06 Mar 2017 | Kuala Lumpur, Malaysia |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Nine Biopharm | $6M | 21 Dec 2021 | Suwon, Ch'ungch'ong-namdo, South Korea | ||
BloomThis | $600K | 06 Mar 2017 | Kuala Lumpur, Malaysia |
